Variant report
Variant | nsv966366 |
---|---|
Chromosome Location | chr4:119342465-119346788 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375547403 | chr4:119342498-119342499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs4103602 | chr4:119342527-119342528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs555129249 | chr4:119342546-119342547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183758205 | chr4:119342602-119342603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs36126235 | chr4:119342610-119342611 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs187657081 | chr4:119342611-119342612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs190741774 | chr4:119342627-119342628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs374510548 | chr4:119342631-119342632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529564120 | chr4:119342660-119342661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182122885 | chr4:119342661-119342662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs34293869 | chr4:119342690-119342691 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs186799984 | chr4:119342701-119342702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191684615 | chr4:119342706-119342707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531855029 | chr4:119342731-119342732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs377687448 | chr4:119342733-119342734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs532103096 | chr4:119342734-119342735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs35733478 | chr4:119342747-119342748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs551340367 | chr4:119342770-119342771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571343351 | chr4:119342797-119342798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs534212807 | chr4:119342805-119342806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs553996229 | chr4:119342810-119342811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs567956647 | chr4:119342814-119342815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536411796 | chr4:119342815-119342816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556738137 | chr4:119342830-119342831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs9759625 | chr4:119342837-119342838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs368156255 | chr4:119342854-119342855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs36032817 | chr4:119342856-119342857 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs544355384 | chr4:119342883-119342884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs372109608 | chr4:119342897-119342898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs377321436 | chr4:119342900-119342901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557775491 | chr4:119342909-119342910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577757102 | chr4:119342912-119342913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs70941169 | chr4:119342913-119342914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188315863 | chr4:119342985-119342986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs143397962 | chr4:119342998-119342999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560450078 | chr4:119343031-119343032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs529206458 | chr4:119343081-119343082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542429663 | chr4:119343094-119343095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs562732834 | chr4:119343157-119343158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs373757249 | chr4:119343174-119343175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531697950 | chr4:119343212-119343213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113848069 | chr4:119343239-119343240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551502301 | chr4:119343250-119343251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565040670 | chr4:119343260-119343261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs527639030 | chr4:119343339-119343340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112327861 | chr4:119343363-119343364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs547401743 | chr4:119343365-119343366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567834973 | chr4:119343403-119343404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs536978462 | chr4:119343411-119343412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs550089254 | chr4:119343426-119343427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Autism | 19246517 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:119340800-119345400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr4:119344200-119345600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr4:119345400-119345600 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr4:119345400-119345800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
5 | chr4:119345400-119345800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr4:119345400-119345800 | Enhancers | Dnd41 | blood |
7 | chr4:119345600-119345800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr4:119346200-119347000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |